Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Guy A Caldwell

1-50 of 68 results

Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies

scientific article

Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model

scholarly article

Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans.

scientific article published in April 2005

Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity

scientific article

Lysosomal impairment in Parkinson's disease

scientific article published on 11 April 2013

Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species.

scientific article published on June 2006

Yeast reveal a "druggable" Rsp5/Nedd4 network that ameliorates α-synuclein toxicity in neurons.

scientific article

Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events

scientific article published on January 2014

Suppression of polyglutamine-induced protein aggregation in Caenorhabditis elegans by torsin proteins

scientific article published in February 2003

MEC-2 is recruited to the putative mechanosensory complex in C. elegans touch receptor neurons through its stomatin-like domain

scientific article published in November 2004

Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models

scientific article published on July 18, 2011

TorsinA participates in endoplasmic reticulum-associated degradation

scientific article

The early-onset torsion dystonia-associated protein, torsinA, is a homeostatic regulator of endoplasmic reticulum stress response

scientific article

Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration.

scientific article

Identification of novel ATP13A2 interactors and their role in α-synuclein misfolding and toxicity

scientific article published on May 29, 2012

C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease.

scientific article published on May 2010

The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans

scientific article published on 22 January 2014

VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease.

scientific article published on 20 October 2009

Generation of stable transgenic C. elegans using microinjection

scientific article

Epileptic-like convulsions associated with LIS-1 in the cytoskeletal control of neurotransmitter signaling in Caenorhabditis elegans

scientific article published on 14 July 2004

The early-onset torsion dystonia-associated protein, torsinA, displays molecular chaperone activity in vitro

scientific article

Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction.

scientific article

Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease

scientific article

Phosphatidylethanolamine deficiency disrupts α-synuclein homeostasis in yeast and worm models of Parkinson disease

scientific article published on September 8, 2014

Chemical enhancement of torsinA function in cell and animal models of torsion dystonia

scientific article

Investigating bacterial sources of toxicity as an environmental contributor to dopaminergic neurodegeneration

scientific article

Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease.

scientific article published on February 2012

The glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models.

scientific article

Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases

scientific article published on 3 July 2013

Genetic interactions among cortical malformation genes that influence susceptibility to convulsions in C. elegans

scientific article published on 22 September 2006

Using Caenorhabditis elegans to probe toxicity of 1-alkyl-3-methylimidazolium chloride based ionic liquids

scientific article published on 10 February 2004

RTCB-1 Mediates Neuroprotection via XBP-1 mRNA Splicing in the Unfolded Protein Response Pathway

scientific article published on November 26, 2014

A Predictable Worm: Application of Caenorhabditis elegans for Mechanistic Investigation of Movement Disorders

scientific article published on April 1, 2012

Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes.

scientific article published on 18 July 2008

Glutaredoxin deficiency exacerbates neurodegeneration in C. elegans models of Parkinson's disease

scientific article

The microtubule-associated protein, NUD-1, exhibits chaperone activity in vitro

scientific article published on 15 July 2008

Pharmacogenetic analysis reveals a post-developmental role for Rac GTPases in Caenorhabditis elegans GABAergic neurotransmission.

scientific article published on 21 September 2009

Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in C. elegans Models of Parkinson's Disease.

scientific article published on 13 October 2017

C. elegans as a model system to accelerate discovery for Parkinson disease

scientific article published on 24 February 2017

TorsinA rescues ER-associated stress and locomotive defects in C. elegans models of ALS

scientific article published on 05 December 2013

Modeling dopamine neuron degeneration in Caenorhabditis elegans

article published in 2011

Paradigms for pharmacological characterization of C. elegans synaptic transmission mutants.

scientific article

Ubiquitin conjugating enzymes participate in polyglutamine protein aggregation

scientific article published on 30 July 2007

Valproic acid ameliorates C. elegans dopaminergic neurodegeneration with implications for ERK-MAPK signaling

scientific article published on February 26, 2013

The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity

scientific article published on 10 February 2018

Animal models for drug discovery in dystonia

scientific article published on January 1, 2008

Caenorhabditis elegans as a model system for identifying effectors of α-synuclein misfolding and dopaminergic cell death associated with Parkinson's disease

scientific article published on 31 December 2010

Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans.

scientific article published on 12 October 2017

Phenazine derivatives cause proteotoxicity and stress in C. elegans

scientific article published on October 7, 2014

NCEH-1 modulates cholesterol metabolism and protects against α-synuclein toxicity in a C. elegans model of Parkinson's disease

scientific article published in October 2017